1954
DOI: 10.2106/00004623-195436020-00019
|View full text |Cite
|
Sign up to set email alerts
|

Arachnoiditis Following the Use of Iodized Oil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0

Year Published

1964
1964
1989
1989

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(4 citation statements)
references
References 0 publications
1
3
0
Order By: Relevance
“…In earlier experimental studies of the action of iodophendylate on meninges (12,13,14,17,18,21,22,23,25), changes have been found which seem to correspond to those described in this paper. In the chronically fibrotic stage, the presence of infiltrates with eosinophilic leucocytes was assumed ( 12), but the authors had no opportunity to observe these since the experimental period did not go beyond seven weeks.…”
Section: Discussionsupporting
confidence: 86%
“…In earlier experimental studies of the action of iodophendylate on meninges (12,13,14,17,18,21,22,23,25), changes have been found which seem to correspond to those described in this paper. In the chronically fibrotic stage, the presence of infiltrates with eosinophilic leucocytes was assumed ( 12), but the authors had no opportunity to observe these since the experimental period did not go beyond seven weeks.…”
Section: Discussionsupporting
confidence: 86%
“…The latter group includes spasmodic contractions, convulsions and epileptic seizures, which according to &e literature occur in 8 to 19 per cent of ch&s after lumbar myelography with the abopmentioned substances (Hurteau 1954 That these muscle spasms can cause severe complications is illustrated by the following two case reports. three groups: meningeal reactions, radi A , r J .…”
mentioning
confidence: 85%
“…There are also a number of experimental situations in which intrathecal therapy is being tried [21,22,29], but none of these have gained wide acceptance. In general, given the difficulties and risks inherent in this route of administration and the possibilities for development of designed drugs that will cross the blood-brain barrier, it appears unlikely that intrathecal therapy will increase much beyond its current level.…”
Section: Intrathecal Therapymentioning
confidence: 99%